Articles
Most mentioned in 2018
Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort
Baron EP., Lucas P. and Hogue O.
Migraine is first cause of disability in under 50s: will health politicians now take notice?
Steiner TJ., Stovner LJ., Vos T., Jensen R. and Katsarava Z.
Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) study
Schwedt TJ, Alam A., Reed ML., Fanning KM., Munjal S. et al.
Medication-overuse headache: a widely recognized entity amidst ongoing debate
Vandenbussche N., Laterza D., Lisicki M., Lloyd J., Lupi C. et al.
The association between migraine and physical exercise
Amin FM., Aristeidou S., Baraldi C., Czapinska-Ciepiela EK., Ariadni DD. et al.
PACAP38 and PAC1 receptor blockade: a new target for headache?
Rubio-Beltrán E., Correnti E., Deen M., Kaam K., Kelderman T. et al.
Pituitary adenylate-cyclase-activating polypeptide (PACAP): another novel target for treatment of primary headaches?
Ashina M., and Martelletti P.
Altered muscle activity during rest and during mental or physical activity is not a trait symptom of migraine - a neck muscle EMG study
Leudtke K., Mehnert J. and May A.
My Migraine Voice survey: a global study of disease burden among individuals with migraine for whom preventive treatments have failed
Martelletti P., Schwedt TJ., Lanteri-Minet M., Quintana R., Carboni V. et al.
Migraine and cluster headache – the common link
Vollesen AL., Benemei S., Cortese F., Labastida-Ramírez A., Marchese F. et al.
(Publication year 2018. Data collected February 2019. Source: Altmetric)
Top cited 2016-2017
Interictal burden attributable to episodic headache: findings from the Eurolight project
Lampl C., Thomas H., Stovner LJ., Tassorelli C., Katsarava Z. et al.
GBD 2015: migraine is the third cause of disability in under 50s
Steiner TJ., Stovner LJ. And Vos T.
Impact of migraine on fibromyalgia symptoms
Giamberardino MA., Affaitati G., Martelletti P., Tana C., Negro, A. et al.
Release of PACAP-38 in episodic cluster headache patients - an exploratory study
Tuka B., Szabó N., Tóth E., Kincses ZT., Párdutz Á. et al.
Calcitonin gene-related peptide and pain: a systematic review
Schou WS., Ashina S., Amin FM., Goadsby PJ. and Ashina M.
Altered kynurenine pathway metabolites in serum of chronic migraine patients
Curto M., Lionetto L., Negro A., Capi M., Fazio F. et al.
The burden of headache disorders in Nepal: estimates from a population-based survey
Manandhar K., Risal A., Linde M. and Steiner TJ.
Headache, depression and anxiety: associations in the Eurolight project
Lampl C., Thomas H., Tassorelli C., Katsarava Z., Miguel Laínez J. et al.
Therapeutic efficacy and safety of Botulinum Toxin A Therapy in Trigeminal Neuralgia: a systematic review and meta-analysis of randomized controlled trials
Morra ME., Elgebaly A., Elmaraezy A., Khalil, AM., Altibi AMA. et al.
Blocking CGRP in migraine patients - a review of pros and cons
Deen M., Correnti E., Kamm K., Kelderman T., Papetti L. et al.
Oxidative stress and DNA damage in patients with migraine
Geyik S., Altunisik E., Neyal AM. and Taysi S.
Altered serum levels of kynurenine metabolites in patients affected by cluster headache
Curto M., Lionetto L., Negro A., Capi M., Perugino F. et al.
European headache federation consensus on technical investigation for primary headache disorders
Mitsikostas DD., Ashina M., Craven A., Diener HC., Goadsby PJ. et al.
Cost-effectiveness analysis of non-invasive vagus nerve stimulation for the treatment of chronic cluster headache
Morris J., Straube A., Diener H-C., Ahmed F., Silver N. et al.
Clinically relevant behavioral endpoints in a recurrent nitroglycerin migraine model in rats
Sufka K., Staszko SM., Johnson AP., Davis ME., Davis RE. et al.
Mindfulness and pharmacological prophylaxis after withdrawal from medication overuse in patients with Chronic Migraine: an effectiveness trial with a one-year follow-up
Grazzi L., Sansone E., Raggi A., D'Amico D., De Giorgio A. et al.
The efficiency of botulinum toxin type A for the treatment of masseter muscle pain in patients with temporomandibular joint dysfunction and tension-type headache
Pihut M., Ferendiuk E., Szewczyk M., Kasprzyk K. and Wieckiewicz M.
Non-invasive Vagus Nerve Stimulation (nVNS) as mini-prophylaxis for menstrual/menstrually related migraine: an open-label study
Grazzi L., Egeo G., Calhoun AH., McClure CK., Liebler E. et al.
Altered effective connectivity of posterior thalamus in migraine with cutaneous allodynia: a resting-state fMRI study with granger causality analysis
Wang T., Chen N., Zhan W., Liu J., Zhang J. et al.
The effect and safety of monoclonal antibodies to calcitonin gene-related peptide and its receptor on migraine: a systematic review and meta-analysis
Hou M., Xing H., Cai Y., Li B., Wang X. et al.
(Publication years 2016-2017). Data collected February 2019. Source: Web of Science)
Heralding a New Era of Episodic, Chronic and Refractory Migraine Management
The scientific summary from the Springer Healthcare IME symposium Heralding a New Era of Episodic, Chronic and Refractory Migraine Management at the 2018 EHF Congress, chaired by Paolo Martelletti, is available to download.
Try the quiz at the end of the report and watch interviews with the faculty as they summarise their presentation here.
European Headache Federation School of Advanced Studies
The European Headache Federation School of Advanced Studies (EHF-SAS) aims to support headache science and offers young EU scientists high quality educational activities to enhance their critical spirit and skills to face headache medicine from a multidisciplinary perspective.
The EHF-SAS covers the richness and diversity of headache medicine fields, including basic science, clinical science, and diagnostic science, and places an emphasis on collaborative projects. The European Headache Federation will support its fellows’ activities allowing them to independently build their own plan sided by the EHF-SAS Scientific Committee.
Editorial Office
Editor in Chief (Founding)
Paolo Martelletti, MD,
Department of Clinical and Molecular Medicine
Sapienza University of Rome
Via di Grottarossa 1035
I-00189 Rome, Italy
Tel.: +39-06-33775111
Fax: +39-06-33775110
E-mail: paolo.martelletti@uniroma1.it
Assistant to the Editor: Valerio De Angelis
E-mail: valerio.deangelis@uniroma1.it
Latest blogs
-
-
-
Hormonal contraceptives in migraine: threats and opportunities
02 September 2018
Aims and scope
The Journal of Headache and Pain is a peer-reviewed open access journal published under the brand SpringerOpen. It is specifically dedicated to researchers involved in all aspects of headache and related pain, including theory, methodology, clinical practice and care. The journal's scope is broad, reflecting the wide application of scientific advances to every branch of headache and related pain management. Within a multidisciplinary perspective, The Journal of Headache and Pain covers headache and related pain syndromes in the following fields: genetics, neurology, internal medicine, clinical pharmacology, child neuropediatrics, anesthesiology, rheumatology, otology, dentistry, neurotraumatology, neurosurgery, psychiatry, pain management, addiction, public health, and epidemiology.
Academic education in headache
The demand for a broad, complete and independent education in Headache Disorders has increased over time. The following international Masters courses guarantee a full coverage of this area of clinical medicine.
For more information:
Master in Headache Medicine - 16th Edition
Academic Year 2018-2019
https://web.uniroma1.it/masterheadache/
Master of Headache Disorders - 2nd Edition
Academic Years 2018-2020
http://mhd.ku.dk
Advertisement
Affiliated with
-
-
The Journal of Headache and Pain is affiliated with the European Headache Federation and Lifting the Burden.
Annual Journal Metrics
-
Speed
30 days to first decision for reviewed manuscripts only
23 days to first decision for all manuscripts
61 days from submission to acceptance
18 days from acceptance to publication
Citation Impact
3.403 - 2-year Impact Factor
3.586 - 5-year Impact Factor
1.091 - Source Normalized Impact per Paper (SNIP)
0.849 - SCImago Journal Rank (SJR)
Usage
725,406 Downloads
- ISSN: 1129-2377 (electronic)
- ISSN: 1129-2369 (print)
Related reading
-
Neuromodulation in Headache and Facial Pain Management
-
Cluster Headache and other Trigeminal Autonomic Cephalgias
-
Peripheral Interventional Management in Headache
-
Placebos and Nocebos in Headaches
-
Gender and Migraine
-
Headache and Comorbidities in Childhood and Adolescence
-
Comorbidities in Headache Disorders
-
Pharmacological Management of Headaches
-
Pathophysiology of Headaches
Advertisement
